Syntax, a leading global technology solutions provider driving enterprise transformation in the cloud, today announced it has received a Golden Certificate from SAP® in recognition of 10 consecutive ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Applied StemCell Corp. (ASC), ...

A local stem cell therapy company added several new investors as part of its Series A expansion. Learn more here.

CHICAGO--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming next generation cell therapies, today announced a research and development collaboration with Mayo Clinic focused on ...

CHICAGO--(BUSINESS WIRE)--Syntax Bio, a preclinical-stage biotechnology company, has launched with backing from Astellas Venture Management LLC and Illumina Ventures. Other investors include DCVCBio, ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced an expanded Series A and new appointments to its executive leadership team, board of ...

Syntax Systems, a global technology solutions and services provider for cloud application implementation and management, has officially acquired Montreal-based Beyond Technologies, enabling the ...

Syntax Bio, a privately held synthetic biology company focused on cell therapies, on Sunday said it expanded its Series A financing round to $14.4 million, bringing total funding raised to more than ...

If there’s one thing you can be sure of, it’s that English Syntax can definitely get interesting. Syntax is the branch of linguistics that deals with sentences and their structures. In case you’re ...